Que Dallara - 11 Mar 2026 Form 4 Insider Report for MiniMed Group, Inc. (MMED)

Role: Chief Executive Officer, Director
Signature: /s/ Bryan F. Kelly, attorney-in-fact
Issuer symbol: MMED
Transactions as of: 11 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 13 Mar 2026, 19:23:51 UTC
Previous filing: 11 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dallara Que	Chief Executive Officer, Director	C/O 18000 DEVONSHIRE STREET, NORTHRIDGE	/s/ Bryan F. Kelly, attorney-in-fact	13 Mar 2026	0001756652

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MMED	Common Stock	Award		+281,937			281,937	11 Mar 2026	Direct	F1, F2, F3, F4
transaction	MMED	Common Stock	Award		+127,609			127,609	11 Mar 2026	Direct	F1, F2, F4, F5
transaction	MMED	Common Stock	Award		+57,239			57,239	11 Mar 2026	Direct	F1, F2, F4, F6
transaction	MMED	Common Stock	Award		+80,842			80,842	11 Mar 2026	Direct	F1, F2, F4, F7
transaction	MMED	Common Stock	Award		+51,044			51,044	11 Mar 2026	Direct	F1, F2, F4, F8
transaction	MMED	Common Stock	Award		+22,892			22,892	11 Mar 2026	Direct	F1, F2, F4, F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA").
F2	Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion").
F3	Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 30, 2027.
F4	Includes shares to be issued in connection with the vesting of one or more restricted stock units.
F5	Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028.
F6	Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026.
F7	Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027.
F8	Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028.
F9	Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in two equal installments on March 10, 2026 and March 10, 2027.